TLR7 agonist RO7020531 versus placebo in healthy volunteers and patients with chronic hepatitis B virus infection: a randomised, observer-blind, placebo-controlled, phase 1 trial.
Lancet Infect Dis
; 23(4): 496-507, 2023 04.
Article
in En
| MEDLINE
| ID: mdl-36509100
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hepatitis B, Chronic
/
Influenza, Human
Type of study:
Clinical_trials
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
Lancet Infect Dis
Journal subject:
DOENCAS TRANSMISSIVEIS
Year:
2023
Document type:
Article
Affiliation country: